Basaljel is an antacid medication containing aluminum carbonate (Al(OH)3) used to treat acid indigestion, heartburn, and excess phosphate in the blood. It provides relief from these symptoms by neutralizing stomach acid and binding to phosphate.
Basaljel is available as a
prescription medication in the form of 500mg capsules. The chemical formula of
Basaljel is CH8Al2O7, also known as aluminum carbonate or dihydroxyaluminum sodium carbonate. It has a
molecular weight of 174.0953 g/mol. The compound consists of an aluminum cation (Al3 ) bonded to carbonate anions (CO32-) in a trigonal structure.
Basaljel belongs to the class of antacid medications. Antacids neutralize stomach acid to provide relief from acid indigestion and heartburn. It is also classified as a
armacology-toxicology-and-pharmaceutical-science/phosphate-binder” target=”_blank”>phosphate binder, which helps lower phosphate levels in the blood by binding to dietary phosphate in the gastrointestinal tract.
Basaljel has several uses and applications, including:
Basaljel works by neutralizing stomach acid and binding to excess phosphate in the gastrointestinal tract. The aluminum ions (Al3 ) in
Basaljel react with hydrochloric acid (HCl) in the stomach to form aluminum chloride (AlCl3) and water (H2O), reducing acidity. Additionally, the carbonate ions (CO32-) bind to phosphate ions (PO43-), forming an insoluble aluminum phosphate complex that is excreted in the feces,
lowering blood phosphate levels.
Basaljel is available as a capsule containing 500mg of aluminum carbonate. The capsules are two-toned, with a red body and white cap, and are imprinted with ”
Basaljel 500 MG.” The oblong-shaped capsules are taken orally, typically with meals or as directed by a healthcare provider. After oral administration,
Basaljel is not systemically absorbed and acts locally in the gastrointestinal tract. The aluminum ions are minimally absorbed, while the carbonate ions dissociate and react with stomach acid. The majority of the drug is excreted unchanged in the feces. Basaljel’s local effect on stomach acid and phosphate binding
occurs within 1-2 hours of administration.
Basaljel is indicated for the treatment of the following conditions: Common side effects of
Basaljel include: Rare but severe side effects may include
allergic reactions, intestinal obstruction, and aluminum toxicity, particularly in patients with impaired renal function. Patients should report any side effects to their healthcare provider.
Basaljel is contraindicated in patients with known hypersensitivity to aluminum-containing products. It should be used with caution in patients with renal impairment, as aluminum accumulation may lead to toxicity. Long-term use of
Basaljel may result in
aluminum absorption and bone toxicity. Patients should not exceed the recommended dosage and duration of treatment.
Basaljel may interact with several medications, including: Patients should inform their healthcare provider about all medications they are taking before starting
Basaljel therapy. Patients should take
Basaljel exactly as prescribed by their healthcare provider. The capsules should be swallowed whole with a glass of water, and should not be crushed, chewed, or opened.
Basaljel is typically taken with meals or as directed. Patients should not take
Basaljel for longer than recommended and should attend regular check-ups to monitor their kidney function and blood phosphate levels.
Basaljel is available by prescription under the brand name
Basaljel and various generic formulations. It is manufactured and distributed by several ph
armaceutical companies worldwide. Patients can obtain
Basaljel from local ph
armacies with a valid prescription from their healthcare provider. Other medications used to treat hyperphosphatemia and acid indigestion include: The choice of treatment depends on the patient’s individual needs, medical history, and potential side effects.
Basaljel has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis. It is a prescription medication and is not available over-the-counter. The safety and efficacy of
Basaljel have been established through clinical trials and post-marketing surveillance. Several clinical studies have investigated the efficacy and safety of
Basaljel in the management of hyperphosphatemia and acid indigestion. A
randomized, double-blind, placebo-controlled trial demonstrated that
Basaljel significantly reduced serum phosphate levels in patients with chronic kidney disease on hemodialysis. Another
study showed that
Basaljel was effective in relieving heartburn and acid indigestion symptoms compared to placebo.
armacist/”>Ph
armacists play a crucial role in educating patients about the proper use of Basaljel. They should provide the following counseling points: The original patent for
Basaljel was filed by the ph
armaceutical company Bieffe Chemical Co. in 1995. Since then, several patents have been granted for various formulations and manufacturing processes related to aluminum carbonate-based phosphate binders. The intellectual property rights for
Basaljel are currently held by multiple ph
armaceutical companies worldwide.
Basaljel is an effective antacid medication used to manage hyperphosphatemia, heartburn, and acid indigestion. Its aluminum carbonate content neutralizes stomach acid and binds to dietary phosphate, providing symptomatic relief and lowering blood phosphate levels. While generally safe,
Basaljel may cause side effects and interact with other medications. Patients should use
Basaljel as directed by their healthcare provider and attend regular check-ups to monitor their response to treatment. Ongoing research continues to investigate the long-term safety and efficacy of
Basaljel in various patient populations.Basaljel: Uses, Side Effects, and Dosage Guide
Table of Contents
Introduction to Basaljel
Chemical Composition and Structure
Drug Classification
Uses and Applications
Mechanism of Action
Dosage Forms and Strengths
armacology”>
armacokinetics/”>Ph
armacokinetics and Ph
armacodynamics
Clinical Indications
Side Effects
Warnings and Precautions
Drug Interactions
Patient Information
Commercial Availability
Alternative Treatments
Regulatory Status
Clinical Studies and Evidence
armacy”>
armacy/”>Ph
armacy Guide
Patent and Intellectual Property
Literature and References
Conclusion
